Edmund Harrigan Incyte Corp (INCY) insider trading activity

INCY Quotes by TradingView

Edmund Harrigan is Director of INCYTE CORP. Currently has a direct ownership of 16,732 shares of INCY, which is worth approximately $1.17 Million. The most recent transaction as insider was on Sep 30, 2024, when has been sold 378 shares (Common Stock) at a price of $66.1 per share, resulting in proceeds of $24,985. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 16.7K
2.31% 3M change
36.27% 12M change
Total Value Held $1.17 Million

EDMUND HARRIGAN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 30 2024
BUY
Grant, award, or other acquisition
$24,985 $66.1 p/Share
378 Added 2.21%
16,732 Common Stock
Jun 28 2024
BUY
Grant, award, or other acquisition
$24,793 $60.62 p/Share
409 Added 2.44%
16,354 Common Stock
Jun 12 2024
BUY
Grant, award, or other acquisition
-
2,830 Added 15.07%
15,945 Common Stock
Mar 28 2024
BUY
Grant, award, or other acquisition
$23,528 $56.97 p/Share
413 Added 3.05%
13,115 Common Stock
Dec 29 2023
BUY
Grant, award, or other acquisition
$26,560 $62.79 p/Share
423 Added 3.22%
12,702 Common Stock
Sep 29 2023
BUY
Grant, award, or other acquisition
$22,472 $57.77 p/Share
389 Added 3.07%
12,279 Common Stock
Jun 30 2023
BUY
Grant, award, or other acquisition
$24,277 $62.25 p/Share
390 Added 3.18%
11,890 Common Stock
Jun 14 2023
BUY
Grant, award, or other acquisition
-
2,505 Added 17.89%
11,500 Common Stock
Mar 31 2023
BUY
Grant, award, or other acquisition
$23,560 $72.27 p/Share
326 Added 3.5%
8,995 Common Stock
Dec 30 2022
BUY
Grant, award, or other acquisition
$24,256 $80.32 p/Share
302 Added 3.37%
8,669 Common Stock
Oct 19 2022
BUY
Grant, award, or other acquisition
$11,482 $69.59 p/Share
165 Added 1.93%
8,367 Common Stock
Sep 30 2022
BUY
Grant, award, or other acquisition
$16,660 $66.64 p/Share
250 Added 2.96%
8,202 Common Stock
Jun 30 2022
BUY
Grant, award, or other acquisition
$17,929 $75.97 p/Share
236 Added 2.88%
7,952 Common Stock
Jun 15 2022
BUY
Grant, award, or other acquisition
-
2,144 Added 21.74%
7,716 Common Stock
Mar 31 2022
BUY
Grant, award, or other acquisition
$19,061 $79.42 p/Share
240 Added 4.13%
5,572 Common Stock
Dec 31 2021
BUY
Grant, award, or other acquisition
$18,570 $73.4 p/Share
253 Added 4.53%
5,332 Common Stock
Sep 30 2021
BUY
Grant, award, or other acquisition
$16,301 $68.78 p/Share
237 Added 4.46%
5,079 Common Stock
Jun 30 2021
BUY
Grant, award, or other acquisition
$17,499 $84.13 p/Share
208 Added 4.12%
4,842 Common Stock
May 26 2021
BUY
Grant, award, or other acquisition
-
1,923 Added 29.33%
4,634 Common Stock
Mar 31 2021
BUY
Grant, award, or other acquisition
$17,798 $81.27 p/Share
219 Added 7.47%
2,711 Common Stock
Dec 31 2020
BUY
Grant, award, or other acquisition
$18,005 $86.98 p/Share
207 Added 7.67%
2,492 Common Stock
Sep 30 2020
BUY
Grant, award, or other acquisition
$16,781 $89.74 p/Share
187 Added 7.56%
2,285 Common Stock

Also insider at

PHAS
PhaseBio Pharmaceuticals Inc Healthcare
Director
ACAD
ACADIA PHARMACEUTICALS INC Healthcare
EH

Edmund Harrigan

Director
Wilmington, DE

Track Institutional and Insider Activities on INCY

Follow INCYTE CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INCY shares.

Notify only if

Insider Trading

Get notified when an Incyte Corp insider buys or sells INCY shares.

Notify only if

News

Receive news related to INCYTE CORP

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on INCY